Aridis Pharmaceuticals : Accelaration/Increase of Financial Obligation

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549




FORM 8-K




CURRENT REPORT
...

Related Keywords

California ,United States ,Los Gatos ,Delaware ,Washington ,Vu Truong ,Nasdaq ,Nasdaq Stock Market ,Aridis Pharmaceuticals Inc ,Securities Exchange ,Exchange Act ,Securities Act ,Securities Exchange Act ,Events That Accelerate ,Direct Financial Obligation ,Off Balance Sheet ,Aridis Pharmaceuticals ,Nasdaq Capital Market ,Note Purchase Agreement ,Streeterville Capital ,Note Agreement ,Pink Sheets ,Secured Promissory Note ,Note Purchase ,Loan Restructuring Agreement ,Triggering Event ,